President, Chief Executive Officer and Chairman of the Board
D. José María Fernández Sousa-Faro, Ph.D.
Fun fact: "I have scuba dived in over 25 countries"
José María founded PharmaMar in 1986 and is currently the Chairman of the Board of Directors and Executive President. He has been a Professor of Biochemistry at the Complutense University of Madrid and the University of Santiago de Compostela, he obtained an MBA from the IESE Business School in Madrid. Dr. Fernández Sousa-Faro has over 90 scientific articles and patents in the field of biochemistry, drug discovery and molecular biology. With more than 35 years of experience in the pharmaceutical industry, he has held positions within the executive management of ICI-Farma, Antibióticos, Zeltia and PharmaMar. He was a member of the Board of Directors of Antibiotics, Penibérica, Biolys, ICI-Farma, Pescanova, Transfesa, Cooper–Zeltia, ICI-Zeltia and Banco Guipuzcoano.
Managing Director, Oncology & Virology Business Units
Luis Mora Capitán
Fun fact: "I explore new routes on my mountain bike whenever I can"
With 30 years’ experience in the pharmaceutical industry and a Degree in Business Administration from the University of Barcelona, Luis Mora began his career as the Financial Controller for Zambon, S.A. and Pharmazam, S.A. in Barcelona and later as Head of Finance for Zambón Portugal. From 1995-2000 he served as Financial Controller with the Antibióticos Group (Montedison), and as Board Member of Vitatene, in Milan, Italy. He joined PharmaMar in 2000 as Chief Financial Officer and was appointed Managing Director in 2008, presiding over the unit through Yondelis®, Aplidin® and ZepzelcaTM approvals in various countries including those regulated by FDA and EMA.
Chief Financial Officer
María Luisa de Francia Caballero
Fun fact: "When I am not in the office you might probably find me hiking the mountains. I love being outdoors when I can relax"
Ms. de Francia has been with PharmaMar and its predecessor Zeltia since 1988 holding various positions in the finance department, and becoming the Chief Financial Officer of Zeltia in 2000, and then for PharmaMar since the PharmaMar-Zeltia merger in 2015. Ms. de Francia holds an undergraduate degree in law, as well as a graduate degree in Business Administration from the Universidad Pontifical Comillas (ICADE) de Madrid. She also is a member of the Board of Directors for GENOMICA subsidiary.